Michael Swarbrick
Westmead Institute for Medical Research, NSW, Australia
Michael Swarbrick is a Senior Research Officer in the Diabetes and Obesity Program at the Garvan Institute of Medical Research, Darlinghurst, Sydney. He also holds an appointment as a Conjoint Senior Lecturer, School of Medical Sciences at the University of New South Wales. Dr. Swarbrick’s research is focused on adipose (fat) tissue and how its normal properties (such as hormone secretion and adaptive thermogenesis) can be exploited to stimulate weight loss and improve metabolic profile in obesity.
Presentations this author is a contributor to:
Hypoxia inducible factor-1α (HIF-1α) is required for β-cell survival in Type 1 diabetes (T1D) caused by immunological insults (#99)
10:00 AM
Amit Lalwani
ADS Basic Orals – Beta Cells